Hikaru Nakajima is an Oncology physician affiliated with St. Luke's Hospital. OpenAlex indexes 12 publications with 233 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
181 E Brown St
East Stroudsburg, PA 183013004
Telephone
570-422-1700Provider last certified this registry record 2 Oct 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Abstract #5440: Pharmacokinetics of ABI-007, cremophor-free nanoparticle formulation of paclitaxel, in Japanese and Chinese patients with malignancies
Cancer Research
2009 - Phase I study of i.v. vinflunine (VFL), a novel microtubule inhibitor, given every three weeks in Japanese patients with solid tumors2008
Similar KOLs
Other experts from the same institution or the same specialty.
Constance Haan, MD
St. Luke's Hospital
Athanasios Fassas
St. Luke's Hospital
Αthanasios Fassas
St. Luke's Hospital
John W Gregory
St. Luke's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”